Drug Database
DO

doxycycline (Perio Product / Atridox / doxycycline, Atrix)

✓ Approved

Pharmascience, Inc. · 小分子 · 小分子

什么是 doxycycline?

doxycycline 是一种小分子,由Pharmascience, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)、Topical。

药物档案

商品名Perio Product, Atridox, doxycycline, Atrix
公司Pharmascience, Inc.
药物类别小分子
给药途径Oral (PO), Topical
状态Approved

治疗适应症

doxycycline 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsPeriodontitis✓ Approved

相关研究文献

PubMedEmerging infectious diseases2026-11-19

Human Discovertebral Infection Caused by Camelimonas Species Bacteria, France, 2025.

Chombart Louis L, Blosse Alice A, Desclaux Arnaud A, Jehanne Quentin Q et al.

We describe a case of human Camelimonas species infection, highlighting this bacterium as a potential emerging zoonotic pathogen with bone tropism. Diagnosis required repeated biopsies and genome sequencing. The isolate was susceptible to trimethoprim/sulfamethoxazole and doxycycline; clinical improvement followed prolonged therapy. Our findings support this bacterium's pathogenic role in humans.

PMID 43053330
阅读全文 →
PubMedProgress in neuro-psychopharmacology & biological psychiatry2026-11-18

Doxycycline attenuates anxiety-like behavior and social deficits during alcohol withdrawal in zebrafish: potential involvement of matrix metalloproteinases.

Eresko Sergei O SO, Airapetov Marat I MI, Ignatova Polina D PD, Shabanov Petr D PD

Alcohol withdrawal syndrome is characterized by anxiety-like behavior, social deficits, and hyperarousal, mechanisms potentially involving extracellular matrix (ECM) remodeling via matrix metalloproteinases (MMPs). Doxycycline (DOX), a tetracycline antibiotic with known MMP-inhibitory properties, has shown neuroprotective effects in various models, but its efficacy in correcting alcohol withdrawal symptoms remains unexplored. We investigated the behavioral effects of DOX (700 μg/L) compared to the reference nootropic piracetam (PIR, 700 mg/L) in adult zebrafish (Danio rerio) subjected to chronic alcohol exposure followed by withdrawal. Behavioral phenotyping included locomotor activity, anxiety-like vertical distribution, social interaction, and danger avoidance tasks. Data were analyzed using one-way ANOVA or Welch's ANOVA followed by appropriate post-hoc tests. Chronic alcohol exposure and subsequent withdrawal induced significant hyperlocomotion, anxiety-like thigmotaxis, and reduced social approach. DOX treatment effectively reversed anxiety-like behaviors and social deficits associated with withdrawal, restoring these parameters to levels statistically indistinguishable from controls. In contrast, PIR primarily normalized locomotor hyperactivity at the habituated stage but failed to correct anxiety or social avoidance parameters. Notably, DOX did not significantly reduce general hyperlocomotion itself, suggesting a dissociation between its anxiolytic/social-restorative effects and motor suppression. In the danger avoidance task, DOX prevented excessive caution observed in untreated withdrawal fish without inducing disinhibition relative to controls. Doxycycline selectively attenuates anxiety-like behavior and social deficits associated with alcohol withdrawal in zebrafish, distinct from its lack of effect on general hyperlocomotion. These findings support the hypothesis that ECM/MMP modulation may offer a targeted therapeutic strategy for affective components of withdrawal syndrome, although direct biochemical confirmation of CNS MMP inhibition is required. The differential profile of DOX versus PIR highlights the specificity of MMP-targeted interventions for emotional regulation rather than general cognitive/motor enhancement.

PMID 43051444
阅读全文 →
PubMedActa tropica2026-11-18

Molecular detection and therapeutic management of Babesia gibsoni and Ehrlichia canis co-infection in dogs along with characterisation of the pathogens.

Pati Mirashree M, Biswal Sangram S, Mishra Smruti Ranjan SR, Dehuri Manaswini M et al.

Tick-borne hemoparasitic infections constitute an important cause of clinical morbidity in dogs, particularly in endemic regions where vector exposure facilitates concurrent transmission of multiple pathogens. This study aimed to molecularly detect and characterise Babesia gibsoni and Ehrlichia canis co-infection in dogs, assess associated clinico-hemato-biochemical alterations, and evaluate the therapeutic efficacy of artesunate-atovaquone-doxycycline (AAD) regimen. A total of 184 clinically suspected dogs were screened by internally controlled multiplex PCR, and positive cases were further confirmed by species-specific real-time quantitative PCR (qPCR) and sequencing. The prevalence of B. gibsoni and E. canis co-infection was 7.6% (14/184). Eight infected dogs were treated with AAD protocol and the relative abundance of parasite target DNA was assessed on days 0, 10, 28, and 90 using relative quantification (RQ) qPCR targeting B. gibsoni 18S rRNA and E. canis VirB9 gene that has been normalized to canine β-actin by the 2-ΔΔCt method. Infected dogs exhibited normocytic-normochromic anaemia, thrombocytopenia, hypoproteinaemia, hyperglobulinaemia, hyperbilirubinemia, azotaemia, high serum alkaline phosphatase and aspartate transaminase level whereas, mean creatinine level were found within normal physiological range. Following AAD therapy, dogs showed rapid clinical recovery, with significant improvement in hemato-biochemical parameters by day 90. Significant reduction in parasite DNA load was noted, reflected by rising Ct values and progressively declining log RQ values for both pathogens. These findings indicated that the AAD regimen showed potential effectiveness against canine B. gibsoni and E. canis co-infection, however this preliminary clinical observation may be validated through further controlled trials.

PMID 43051342
阅读全文 →
PubMedArthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association2026-11-17

Gelatin-Coated High-Strength Commercial Sutures Show Antibiotic Elution With Distinct Release Kinetics: An In Vitro Study.

Maity Apratim A, Fay Caroline A CA, Neufeld Eric V EV, Grande Daniel A DA et al.

To develop a reproducible technique for coating high-strength sutures with doxycycline or vancomycin and to compare the antibiotic elution profiles of round and tape-style sutures over time in an in vitro model. In this in vitro study, 2 round (No. 2 FiberWire [PE-R, polyethylene-core round], No. 2 ActivBraid [COL-R, collagen-integrated round]) and 2 tape-style (1.5 mm LabralTape [PE-T, polyethylene-core tape], 1.5 mm ActivBraid [COL-T, collagen-integrated tape]) sutures were dip-coated in gelatin solutions containing low (C1) or high (C2) doxycycline or vancomycin concentrations. After drying, 1-cm segments were incubated at 37°C, and daily aliquots were collected over 7 days. Antibiotic release was quantified by enzyme-linked immunosorbent assay. Total doxycycline and vancomycin elution ranged from 83.6 to 151.8 ng and 261.3 to 319.1 ng, respectively. Doxycycline showed first-order-like elution, with the greatest occurring during days 1 to 3. In contrast, vancomycin showed near-constant elution with minor fluctuations over time. At individual timepoints, COL-T (C1D) released more doxycycline than COL-R on days 2 and 3, whereas COL-T released more than COL-R on day 5 in C2D. COL-R (C1V, C2V) released more vancomycin than PE-R on day 5. Conversely, COL-R (C2D) released less doxycycline than PE-R on day 6. Intergroup comparisons showed that PE-T released more vancomycin in C2V versus C1V on day 3, and PE-R released more vancomycin in C1V versus C2V on day 5 and more doxycycline in C1D versus C2D on day 6. Coating commercial high-strength sutures with either doxycycline or vancomycin using a gelatin-based dip-coat produced measurable, but low-level, antibiotic elution over 7 days in this in vitro model. Doxycycline exhibited a release profile consistent with first-order kinetics characterized by a higher initial burst followed by tapering elution, whereas vancomycin showed a more sustained release pattern consistent with near zero-order kinetics. Among the coated constructs, COL-T sutures exhibited the greatest doxycycline elution, whereas COL-R sutures exhibited the greatest vancomycin elution relative to PE-R sutures. Antimicrobial coating of high-strength orthopaedic sutures enables sustained local antibiotic elution and may provide a potential strategy for reducing the early postoperative infection risk in tendon and ligament repairs.

PMID 43043649
阅读全文 →
PubMedRSC advances2026-11-17

Unveiling the dual Z-scheme g-C3N4/Sm2O3/Gd2O3 heterostructure for efficient photocatalytic detoxification of tetracycline antibiotics with reduced phytotoxicity.

Mishra Priyanka P PP, Behera Ajaya Kumar AK, Das Nigamananda N, Manna Suvendu S

The pervasive occurrence of antibiotic residues in aquatic systems necessitates transformative remediation strategies to safeguard public health and ecosystems. In this work, we report the rational design of a dual Z-scheme heterostructure photocatalyst for the efficient degradation of tetracycline and doxycycline from aquatic environments. A series of ternary composites were fabricated by embedding different wt% of binary Sm2O3/Gd2O3 (S1) into the g-C3N4 matrix via a hydrothermal/ultrasonication-assisted approach, followed by comprehensive physicochemical characterization to elucidate the impact of binary oxides in modulating the g-C3N4 framework. Morphological investigation revealed the in situ growth of binary oxides within the layered stacking of g-C3N4, while radical scavenging and Mott-Schottky plots corroborated the dual Z-scheme charge transfer pathway. The optimized CS-10 composite exhibited superior photoactivity, achieving 93% tetracycline and 91% doxycycline removal (50 mg L-1) within 60 minutes of light irradiation, with recyclability sustained over four cycles. Phytotoxicity assays using Vigna radiata also showed enhanced root and shoot growth in the CS-10 composite, indicating reduced effluent toxicity and validating environmental applicability. Overall, these findings establish the CS-10 catalyst as a robust and scalable photocatalyst with significant potential for mitigating antibiotic contamination in pollutant-laden matrices.

PMID 43041988
阅读全文 →
PubMedSexually transmitted diseases2026-11-17

Doxycycline Post-Exposure Prophylaxis Knowledge, Attitudes, and Practices Among HIV and PrEP Providers in Two NYC Academic Medical Centers: A Cross-Sectional Pilot Survey.

Arens Yotam Y, Yoon Cecilia C, Zucker Jason J

Doxycycline post-exposure prophylaxis (doxy-PEP) reduces sexually transmitted infections (STIs) among vulnerable populations. Effective implementation depends on willingness to prescribe, yet data on provider knowledge, attitudes, and practices in New York City (NYC) remain limited. We conducted a cross-sectional survey of providers at two NYC academic medical centers between May-September 2025. Eligibility required prescribing antiretroviral therapy or PrEP (pre-exposure prophylaxis) to ≥ 5 patients in the prior year. The online questionnaire adapted from a PrEP acceptability instrument measured provider doxy-PEP knowledge, attitudes, prescribing practices, and perceived barriers. Knowledge scores were summed from correct responses; attitudes on a 4-point Likert scale were transformed to reflect positive views and summed. Median total scores were compared between primary care (non-specialists) and Infectious Disease/HIV (specialists) providers using one-sided Mann-Whitney U-tests to assess whether non-specialists had lower knowledge and attitude scores. Prescribing practices were compared with Fisher's exact test. Thirty-eight eligible providers completed the survey (28 specialists, 10 non-specialists); 97% prescribed doxy-PEP previously. Specialists managed significantly larger HIV/PrEP patient panels (p<0.01). Non-specialists demonstrated lower objective doxy-PEP knowledge than specialists (median composite score 57% vs 86%, p < 0.01), particularly regarding efficacy and dosing. Doxy-PEP attitudes were favorable in both groups (median composite score 3.3 vs 3.4, max 4, p = 0.05). Concerns about antimicrobial resistance (49%) and side effects (30%) were the most reported prescribing barriers. Non-specialists endorsed favorable doxy-PEP attitudes but had lower objective knowledge. Barriers including resistance and adverse effects highlight opportunities for targeted education to improve doxy-PEP knowledge and prescribing confidence among generalist providers.

PMID 43043924
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多doxycycline